Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

UV betreur afsterwe van baanbreker
2006-06-21

Die hoofbestuur van die Universiteit van die Vrystaat (UV) het met hartseer verneem van die afsterwe van dr. Barnie Human.

 Dr. Human het ‘n B Com- en honneursgraad aan die UV verwerf.  Sy  bande met die UV strek oor amper veertig jaar.   Hy was vanaf 1967-1995 lid van die UV-Raad en was vir meer as dertig jaar betrokke by fondswerwingsprojekte vir die Ontwikkelingstrustfonds van die UV.  In 1977 is hy verkies tot nasionale voorsitter van die UOVS Oudstudente Reünie, voorloper van die latere Kovsie-Alumni Bond.  Hy is in 1981 deur sy alma mater vereer met ‘n eredoktorsgraad in ekonomie. 

 Dr. Human, wat deurlopend baie aktief betrokke by die aktiwiteite van die Kovsie- Alumni Bond, het in 1985 die Bond se hoofbestuurstoekenning ontvang vir uitsonderlike diens gelewer aan die UV.  Hy is ook in 1993 aangewys as ere-trustee van die Ontwikkelingstrustfonds.

 In Oktober 2004 het die UV hom vereer met ‘n Eeufeesmedalje vir sy bydrae tot die ontwikkeling van die UV se fondsinsamelingsaksies, veral ten opsigte van die vestiging van fisiese fasiliteite op die Hoofkampus in Bloemfontein.  Sy geldelike bydrae het die UV in staat gestel om die Callie Human-sentrum te bou.  Die sentrum is ter nagedagtenis van sy seun, Callie wat in 1967 in ‘n motorfietsongeluk oorlede is, opgerig.

 “Dr. Human was ‘n ware steunpilaar vir die UV.  Ons is dankbaar dat ons hom in 2004 daarvoor kon vereer met ‘n Eeufeesmedalje voor sy afsterwe,” sê prof. Frederick Fourie, Rektor en Visekanselier van die UV.

 “Ons simpatiseer ook met mev. Swannie Human en die egpaar se dogter, mev. Christina Strydom.  Dr. Human laat nie net ‘n leemte in die Bloemfonteinse sakewêreld nie, maar ook in die harte van die mense aan die UV wat hom geken het en saam met hom gewerk het,” sê prof. Fourie.

 Mediaverklaring
Uitgereik deur: Lacea Loader
Mediaverteenwoordiger
Tel:  (051) 401-2584
Sel:  083 645 2454
E-pos:    loaderl.stg@mail.uovs.ac.za
21 Junie 2006

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept